Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD83 antigen is a cell surface glycoprotein predominantly expressed on mature dendritic cells, activated T and B lymphocytes, monocytes, macrophages, neutrophils, and some thymic epithelial cells in mammals. The human protein is encoded by the CD83 gene on chromosome 6p23 and consists of an extracellular Ig-like V domain, a transmembrane segment, and a short cytoplasmic tail. Both membrane-bound (mCD83) and soluble (sCD83) forms exist: mCD83 is a potent marker for mature dendritic cells and is involved in antigen presentation, while sCD83 has immune-suppressive properties. CD83 regulates immune responses, controls T and B cell differentiation, and maintains peripheral tolerance predominantly through modulating dendritic cell phenotype and influencing regulatory T cell functions. Its immune checkpoint-like activity gives CD83 therapeutic relevance for autoimmune diseases, transplant rejection, and certain viral infections, with monoclonal antibodies and recombinant proteins in preclinical and early clinical-stage studies. Potential risks include over-immune suppression and impaired pathogen clearance.
Immune suppression (soluble CD83); Immunomodulation by antagonizing E3 ubiquitin ligases affecting costimulatory molecules and MHC II stability; Promotion of immune tolerance by supporting regulatory T cells (Treg) and modulating dendritic cell activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD83 antigen (CD83).